Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype

We discovered a new chemical class of antiproliferative agents, 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides. SAR-guided optimization of the two distinct terminal fragments yielded a compound with 120 nM potency in an antiproliferative assay. Biological activity profile studies (COMPARE analysis) demonstrated that 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides act as tubulin inhibitors, and this conclusion was confirmed via biochemical assays with pure tubulin and demonstration of increased numbers of mitotic cells following treatment of a leukemia cell line. © 2014 Elsevier Ltd. All rights reserved.

Авторы
Krasavin M.1 , Sosnov A.V.2 , Karapetian R.3 , Konstantinov I.3 , Soldatkina O.3 , Godovykh E.3 , Zubkov F. 4 , Bai R.5 , Hamel E.5 , Gakh A.A.6, 7, 8
Издательство
Elsevier Ltd
Номер выпуска
18
Язык
Английский
Страницы
4477-4481
Статус
Опубликовано
Том
24
Год
2014
Организации
  • 1 Department of Chemistry, St. Petersburg State University, Peterhof, 198504, Russian Federation
  • 2 ORCHIMED, Institute of Physiologically Active Compounds, Chernogolovka, Moscow Region, 142432, Russian Federation
  • 3 Chemical Diversity Research Institute, Khimki, Moscow Region, 114401, Russian Federation
  • 4 Peoples' Friendship University of Russia, Moscow, 117198, Russian Federation
  • 5 National Institutes of Health, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD 21702, United States
  • 6 Oak Ridge National Laboratory, Oak Ridge, TN 37831, United States
  • 7 University of Virginia, Charlottesville, VA 22908, United States
  • 8 Discovery Chemistry Project, Bethesda, MD 20824, United States
Ключевые слова
Chemotherapeutic agents; DU-145; Prostate cancer; Rational single-molecule polypharmacy; Screening; Tubulin inhibitor
Цитировать
Поделиться

Другие записи